Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BLF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,358
Award facts
- Contract value 100% obligated
- $14,358.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,358.15 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made on a competitive basis with no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and running through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has established itself through consistent performance on multiple delivery orders covering diverse pharmaceutical products including specialty medications, vaccines, and medical supplies across various therapeutic domains. The supply of Ozempic, a diabetes medication, aligns with AmerisourceBergen's demonstrated portfolio in endocrinology treatments and reflects the company's role in supporting military medical logistics and veteran healthcare initiatives through the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9BLF?
SPE2DR26F9BLF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F9BLF worth?
The government has obligated $14,358 on SPE2DR26F9BLF.
Is contract SPE2DR26F9BLF an order under another contract?
Yes. SPE2DR26F9BLF is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BLF competed?
The extent of competition for SPE2DR26F9BLF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award